Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - EXACT Sciences Corp. (NasdaqNM:EXAS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
63 Great Road
Maynard, MA 01754
Phone: (978) 897-2800
Fax: (978) 897-3481
Email: info@exactsciences.com
Employees (last reported count): 44
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 50%
·Over the last 6 months:
 · one insider sell; 2,000  shares
·Institutional: 19% (37% of float)
(39 institutions)
·Net Inst. Selling: 105.0K shares (+3.13%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
EXACT Sciences Corporation has developed proprietary technologies in applied genomics that will assist in the early detection of colorectal cancer and several other types of common cancers. The Company has selected colorectal cancer as the first application of its technology platform because it is the most deadly cancer among non-smokers, curable if detected early and has been studied from a genomics point of view. The Company has developed proprietary technologies that isolate the human DNA shed from the colon into stool. It then identifies mutations in DNA shed from abnormal cells associated with colorectal cancer and pre-cancerous lesions. The Company has conducted blinded clinical studies at the Mayo Clinic that may indicate that its tests are able to detect colorectal cancer more accurately in patients who have the disease at an earlier stage than methods available for mass screening for colorectal cancer.
More from Market Guide: Expanded Business Description

Financial Summary
EXACT Sciences Corporation has developed proprietary technologies in applied genomics that the Company believes will enable the early detection of colorectal cancer and several other types of common cancers. For the six months ended 6/30/01, the Company reported no revenues. Net loss totaled $11.1 million, up from $3.9 million. Higher loss reflects increased personnel expenses and professional fees and higher stock-based compensation costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Stanley Lapidus, 51
Chairman
$287K$105K
Don Hardison, 50
Pres, CEO, Director
407K400K
John McCarthy, Jr., 42
CFO, Exec. VP
50K300K
Stephen Read
VP, Controller
--  --  
David Nikka
VP, Resources and Devel.
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:EXASAs of 31-Aug-2001
Price and Volume
52-Week Low
on 9-Apr-2001
$5.30 
Recent Price$9.85 
52-Week High
on 31-Jan-2001
$17.00 
Daily Volume (3-month avg)100.5K
Daily Volume (10-day avg)96.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-10.5%
26-Week Change
relative to S&P500
-2.5%
Share-Related Items
Market Capitalization$183.6M
Shares Outstanding18.6M
Float9.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.72 
Earnings (ttm)-$5.53 
Earnings (mrq)-$0.32 
SalesN/A 
Cash (mrq)$3.61 
Valuation Ratios
Price/Book (mrq)2.65 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$17.1M
Income available to common (ttm)-$19.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-36.57%
Return on Equity (ttm)-37.50%
Financial Strength
Current Ratio (mrq)37.36 
Debt/Equity (mrq)0 
Total Cash (mrq)$67.2M
Short Interest
As of 8-Aug-2001
Shares Short276.0K
Percent of Float3.0%
Shares Short
(Prior Month)
217.0K
Short Ratio1.96 
Daily Volume141.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.